https://www.selleckchem.com/pr....oducts/mpp-dihydroch
014). The mutation rate of driver gene Ephrin-A2 ( ) was significantly reduced after radiotherapy (Fisher's exact test, P=0.035). However, comparison between the pre- and post-radiotherapy groups reveals no significant differences in other content. Our study revealed the overall genomic profile of ESCC before and after radiotherapy and determined that a loss of mutations might make cancer cells resistance to radiotherapy. Our study revealed the overall genomic profile of ESCC before and after radiotherapy and determined that